Alkahest is a new first-person fantasy action-adventure RPG from developer Push On that bills itself as a spiritual successor to Dark Messiah of Might & Magic while also citing Dishonored and ...

Get your first tease of gameplay from Alkahest, a new first-person medieval fantasy action-adventure RPG from developer Push On that bills itself as a spiritual successor to Dark Messiah of Might ...

--Alkahest, Inc., a clinical stage biotechnology company focused on discovering and developing transformative therapies to treat age-related diseases and a subsidiary of Grifols, today announced ...

On May 22, 2025, IGN showed off a teaser trailer for a new upcoming Xbox title with a similarly upcoming PC port named Alkahest. This game, developed by Push On and published by HypeTrain Digital ...

--Alkahest, Inc., a clinical-stage biotechnology company focused on discovering and developing transformative therapies to treat age-related diseases and a subsidiary of Grifols, today announced ...

"Alkahest is an action-adventure RPG set in a murky medieval world, where satisfying melee combat with highly interactive environments takes center stage," the newly-revealed Steam page says.

SAN CARLOS, Calif., Aug. 05, 2019 (GLOBE NEWSWIRE) -- Alkahest, Inc., a clinical-stage biotechnology company focused on developing transformative therapies to treat age-related diseases, today ...

Watch on YouTube Subscribe to Push Square on YouTube 160k Currently targeting PC and "consoles", Alkahest is an intriguing first-person action RPG, boasting a fairly grounded medieval setting.

For $8,000, a startup called Ambrosia plans to sell transfusions of young blood for anti-aging purposes. Another longevity company called Alkahest is also focused on blood. But it's taking a very ...

SAN CARLOS, Calif., Jan. 28, 2021 (GLOBE NEWSWIRE) -- Alkahest, Inc., a clinical stage biotechnology company focused on discovering and developing transformative therapies to treat age-related ...

Alkahest founder and Stanford University professor Tony Wyss-Coray. Norbert von der Groeben/Stanford School of Medicine.

SAN CARLOS, Calif., March 08, 2021 (GLOBE NEWSWIRE) -- Alkahest, Inc., a clinical stage biotechnology company focused on discovering and developing transformative therapies to treat age-related ...